Emely Thompson

Emely Thompson is a skilled healthcare policy reporting specialist currently working at Policy Reporter since January 2022. Previous experience includes roles as a Research & Reporting Analyst and Research Technician at The University of British Columbia, where extensive data analysis and administrative support were provided. Emely’s academic background encompasses a Ph.D. in Pharmacology from The University of British Columbia, an MSc in Cancer Therapeutics from Queen Mary University of London, and a Bachelor’s degree from the University of Hertfordshire. Additional research experience includes conducting studies for the European Commission and Barts Cancer Institute, focusing on medical research outcomes and drug screening in cancer therapies, respectively. Emely's expertise spans molecular and cellular techniques, statistical analysis, and reporting in healthcare policy contexts.